Page 40 - Development Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novel brain injury treatment tested in 1st human subject; drug conceived at UT Health San Antonio

SAN ANTONIO, TEXAS, AND GROTON, CONN. (PRWEB) June 16, 2022 SAN ANTONIO, TEXAS, AND GROTON, CONN. (Wednesday, June 15, 2022) An experimental brain injury

San antonioUnited statesBexar countyJames lechleiterJamesd lechleiterAndrea giuffridaTed listonUs department of defenseAstrocyte pharmaceuticalsUs army medical researchDrug administrationOffice of technology commercializationUt health san antonioTechnology enterprise consortiumTexas health science centerTechnology commercialization

Novel brain injury treatment tested in 1st human subject; drug conceived at UT Health San Antonio

Novel brain injury treatment tested in 1st human subject; drug conceived at UT Health San Antonio
whatsuppub.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whatsuppub.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesBexar countyJamesd lechleiterAndrea giuffridaTed listonUs department of defenseAstrocyte pharmaceuticalsUs army medical researchDrug administrationOffice of technology commercializationUt health san antonioTechnology enterprise consortiumTexas health science centerTechnology commercializationMedical technology enterprise consortium

Astrocyte Announces Initiation of First-In-Human Phase 1 Study of the Promising Stroke and Traumatic Brain Injury Therapeutic, AST-004

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesWilliam korinekElisa mannaAstrocyte pharmaceuticalsAstrocyte pharmaceuticals incDepartment of defenseUs army medical researchAmerica department of defenseDepartment of the armyClinical development operations at astrocyteTechnology enterprise consortiumDevelopment commandPharmaceuticals incMedical technology enterprise consortiumMedical researchAmerica department

AMIVAS Ireland Ltd Receives Authorisation from the Medicines & Healthcare Products Regulatory Agency (MHRA) to Market Artesunate Amivas (artesunate) in U K for Initial Treatment of Severe Malaria

/PRNewswire/ AMIVAS Ireland Ltd., specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today the.

United statesUnited kingdomSheilaa burkeMark reidBryan smithSean powerArtesunate amivasCenters for diseaseDepartment of defense doIreland ltdUs army medical researchDrug administrationWalter reed armyOffice of the surgeonUs army medical materiel development activityDevelopment of artesunate amivas

Trauma Triage Treatment and Training Decision Support (4TDS)

Trauma Triage Treatment and Training Decision Support (4TDS)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioNew mexicoSteven antrimEric elsterMatthew dangeloNatalie keeneyAdam amos binksChristopher nemethVitaly herasevich mayoJaques reifmanSoftware applications instituteUs army medical researchResearch associates incGreg rule applied research associates incUniformed services university of health sciences